1. Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action
   Xia Yang et al, 2018, FEBS Open Bio CrossRef
2. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
   Z.-S. Yao et al, 2018, Cancer Biomarkers CrossRef
3. hsa_circ_0041795 contributes to human retinal pigment epithelial cells (ARPE 19) injury induced by high glucose via sponging miR-646 and activating VEGFC
   Hao Sun et al, 2020, Gene CrossRef
4. Noncoding RNAs in liver cancer patients
   Julie Sanceau et al, 2022, Clinical Applications of Non-Coding RNAs in Cancer CrossRef
5. MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem
   Ning Liu et al, 2022, Cancers CrossRef
6. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition
   Xiaodong Xie et al, 2017, Oncology Letters CrossRef
7. MicroRNA-mediated regulation of Nrf2 signaling pathway: Implications in disease therapy and protection against oxidative stress
   Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef
8. Unraveling the hypoxia modulating potential of VEGF family genes in pan-cancer
   So-Hyun Bae et al, 2023, Genomics & Informatics CrossRef
9. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
   Wei Jiang et al, 2017, Journal of Gynecologic Oncology CrossRef
10. Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
    Shunhao Zhang et al, 2022, Frontiers in Pharmacology CrossRef
11. Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis
    Yuanqi Liu et al, 2018, Journal of Natural Medicines CrossRef
12. Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway
    Ai-Mei Gao et al, 2017, Oncotarget CrossRef
13. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
    Taisuke Imamura et al, 2017, Oncotarget CrossRef
14. microRNAs: Key players in virus‐associated hepatocellular carcinoma
    Javid Sadri Nahand et al, 2019, Journal of Cellular Physiology CrossRef
15. Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma
    Mankgopo M. Kgatle et al, 2016, BioMed Research International CrossRef
16. New Insights into the Epigenetics of Hepatocellular Carcinoma
    Braira Wahid et al, 2017, BioMed Research International CrossRef
17. miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC
    Pingping Tao et al, 2017, Experimental and Therapeutic Medicine CrossRef
18. c‐Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
    Tsung‐Ming Chang et al, 2021, Cancer Science CrossRef
19. MicroRNA‐101a‐3p could be involved in the pathogenesis of temporomandibular joint osteoarthritis by mediating UBE2D1 and FZD4
    Dan Mao et al, 2021, Journal of Oral Pathology & Medicine CrossRef
20. MicroRNA dysregulation interplay with childhood abdominal tumors
    Karina Bezerra Salomão et al, 2019, Cancer and Metastasis Reviews CrossRef
21. Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells
    Chih-Yang Lin et al, 2017, Cell Death & Disease CrossRef
22. NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo
    Huihui Zhang et al, 2022, BMC Urology CrossRef
23. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
    Dai Shimizu et al, 2017, Oncology Reports CrossRef